Price Alert

Achieve Life Sciences Inc... (ACHV)

NASDAQ: ACHV · Real-Time Price · USD

3.08

-0.10 (-3.14%)

At close: Oct 16, 2025, 3:59 PM

-3.14% (1D)

Bid	3.06
Market Cap	157.4M
Revenue (ttm)	228K
Net Income (ttm)	-50.42M
EPS (ttm)	-1.48
PE Ratio (ttm)	-2.08
Forward PE	-2.99
Analyst	Buy
Dividends	n/a

Ask	3.29
Volume	452,431
Avg. Volume (20D)	980,462
Open	3.22
Previous Close	3.18
Day's Range	3.06 - 3.24
52-Week Range	1.84 - 5.31
Beta	1.58
Ex-Dividend Date	n/a

About ACHV

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ACHV

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ACHV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 month ago

+12.02%

Achieve Life Sciences shares are trading higher af... Unlock content with Pro Subscription

3 months ago

-36.47%

Achieve Life Sciences shares are trading lower after the company announced a $45 million public offering.

News

1 month ago · benzinga.com

Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years

Achieve Life Sciences Inc. ACHV is moving closer to a pivotal moment as it seeks FDA approval for cytisinicline, a potential first new smoking cessation therapy in nearly two decades, positioning the ...

2 months ago · seekingalpha.com

Achieve Life Sciences, Inc. (ACHV) Q2 2025 Earnings Call Transcript

Achieve Life Sciences, Inc. (NASDAQ:ACHV ) Q2 2025 Earnings Call August 7, 2025 8:30 AM ET Company Participants Cindy Jacobs - Former President & Chief Medical Officer Jaime Xinos - Chief Commercial O...

2 months ago · fool.com

Achieve (ACHV) Q2 Net Loss Hits $12.7M